Patent US4115195A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4115195A Expired / Lapsed US ⏱️ 0.0 years remaining

Rabies vaccine preparation

Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1977-04-12
•
Granted: 1978-09-19
•
Expires: 1997-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A rabies vaccine is prepared by adaptation of the rabies virus to chick-embryo fibroplast cell cultures in progressing dilutions of from 10-1 to 10-5 for the inoculation of the cell culture passages and for multiplication in dilutions of from 10-2 to 10-5 for inoculation of the growth cultures.

Inventors

  • 👤 Rudolph Barth
  • 👤 Oskar Jaeger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 06:05
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/12; A61K39/205; A61K2039/51; A61K2039/525; A61K2039/5252; C; C12; C12N; C12N2760/00; C12N2760/00011; C12N2760/20011; C12N2760/20111; C12N2760/20134; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 73 words
In a process for preparing a rabies vaccine, the improvement wherein the rabies virus is first adapted to chick-embryo fibroblast cell cultures using a suspension containing the rabies virus in progressing dilutions from 10 -1 to 10 -5 for the inoculation of the cell culture passages and then inoculating growth cultures with a suspension containing the adapted rabies virus in a dilution from 10 -2 to 10 -5 for multiplication of the virus.
Claim 2
Dependent Claim 73 words
In a process for preparing a rabies vaccine, the improvement wherein the rabies virus is first adapted to chick-embryo fibroblast cell cultures using a suspension containing the rabies virus in progressing dilutions from 10 -1 to 10 -5 for the inoculation of the cell culture passages and then inoculating growth cultures with a suspension containing the adapted rabies virus in a dilution from 10 -2 to 10 -5 for multiplication of the virus.
Claim 3
Dependent Claim 24 words
A process as claimed in claim 1, wherein during the passages the temperature is maintained in the range of from 30° to 38° C.
Claim 4
Dependent Claim 24 words
A process as claimed in claim 1, wherein during the passages the temperature is maintained in the range of from 32° to 37° C.
Claim 5
Dependent Claim 20 words
A process as claimed in claim 1, wherein chick-embryo fibroblast cells of SPF eggs are used for the vaccine production.

References Cited (Backward Citations)

US2768114A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-09-18 1982-03-20 1982-09-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-09-18 1986-03-20 1986-09-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-09-18 1990-03-20 1990-09-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag